Combined Angioplasty and Femorofemoral Bypass in the Treatment of Unilateral Iliac Arterial Occlusive Disease

PURPOSE: The purpose of this article is to analyze the results of combined agioplasity and femorofemoral bypass in patients with unilateral iliac arterial occlusive disease. METHOD: During the 11-year period from 1990 to 2000, 44 patients with iliac artery occlusion and a hemodynamically significant contralateral iliac artery stenosis were treated by using a combination of percutaneous transluminal angioplasity (PTA) and femorofemoral bypass (n=18) as well as aortobifemoral bypass (n=12) and iliofemoral bypass (n=14) at Korea university medical center. PTA was performed if the lesions in the donor iliac artery were less than 3 cm in length with no more than one well-localized lesion in either the common or external iliac artery, or both. Stent was deployed for suboptimal PTAs. The femorofemoral bypass was done within 3 to 5 days after PTA or stenting. RESULT: The mean age was 61.2 years. The Indications of femorofemoral bypass were hypertension, ischemic heart disease, chronic obstructive lung disease, old age (>75), cancer, and previous abdominal operation. The complication rate of the combination treatment was lower than that of the others. Primary patency rate at 1 and 3 years were 89%, 78% for aortobifemoral bypass, 83%, 66% for iliofemoral bypass, and 77%, 65% for femorofemoral bypass, respectively. CONCLUSION: The combination of PTA with or without stent deployment and femorofemoral bypass can be a useful option for treating iliac occlusion and contralateral iliac stenosis in patients with severe comorbid illness, advanced age, and intra-abdominal pathology. Angioplasity can allow more widespread use of femorofemoral bypass in these patients.

A Clinical Review of Acute Superior Mesenteric Ischemic Disease

PURPOSE: The prevalence and incidence of the superior mesenteric ischemic diseases are increasing nowadays because of the increase of aged people and cardiovascular diseases. The morbidity and mortality of the superior mesenteric ischemic diseases are so high and detrimental because acute mesenteric infarction results post operatively reperfusion injury short bowel syndrome and sepsis. A successful management requires very efficient diagnostic and therapeutic measures. So, we reviewed the medical records of superior mesenteric ischemic diseases and identified the clinical and therapeutic characters of these disease. METHOD: Between January 1991 and December 2000, 33 patients with a clinical diagnosis of superior mesenteric ischemic diseases supported by clinical and imaging studies were included in this study. The medical records of the 33 patients who had admitted Korea University Hospital were reviewed retrospectively and identified the clinical characters, the diagnostic tools, underlying diseases and the therapeutic modalities. RESULT: The most common cause of theses disease was the superior mesenteric arterial embolism and the peak incidence was identified in 7th and 8th decades. These diseases were diagnosed with physical examination, abdominal CT or angiogram, but almost half of them were identified at the operative field. 29 patients were treated surgically and the rest of them were medically. At result 12 patients died of these diseases (36.4%). The high WBC count (15,000/ml) and shock were considered as prognostic factors predicting for the mortality (p=0.005). CONCLUSION: The old persons who were suffered from the nonspecific abdominal pain should be suspected of these diseases and treated with properly applied diagnostic tools and therapeutic modalities, especially they show the leukocytosis and the clinical evidence of shock.